THIRD HARMONIC BIO INC (THRD) Stock Analyst Ratings
NASDAQ:THRD - Nasdaq - US88427A1079 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to THRD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 17.34. This target is 433.54% above the current price.
THRD was analyzed by 12 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about THRD.
In the previous month the buy percentage consensus was at a similar level.
THRD was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-11 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2024-08-09 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2024-06-18 | Stifel | Initiate | Buy |
| 2024-06-07 | Raymond James | Initiate | Outperform |
| 2023-08-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2022-12-16 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2022-12-16 | Jefferies | Downgrade | Buy -> Hold |
| 2022-10-10 | Cowen & Co. | Initiate | Outperform |
| 2022-10-10 | Morgan Stanley | Initiate | Overweight |
| 2022-10-10 | Jefferies | Initiate | Buy |